With the many advancements in immuno-oncology for the treatment of renal cell carcinoma following SITC's initial RCC guideline on the subject first published in 2016, the SITC Cancer Immunotherapy Guidelines Renal Cell subcommittee reconvened, resulting in an updated new consensus statement: "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)."This consensus statement provides expert evidence-based recommendations for the use of FDA-approved immune checkpoint inhibitor-based combination therapies and includes recommendations for patient selection, treatment and toxicity management, sequencing of therapies and different histologies.
Published Nov. 15, 2016 in the Journal for ImmunoTherapy of Cancer (JITC) as "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma."
Key points from SITC's Cancer Immunotherapy Guidelines Renal Cell Carcinoma have been distilled into Pocket Guide. This condensed, easily accessible version of the full Cancer Immunotherapy Guideline is a quick-reference tool available in both digital and print.Download SITC's Cancer Immunotherapy Guidelines Renal Cell Carcinoma Pocket Guide on any desktop or mobile device today.*
*Available only through the Guideline Central App.
ORDER Digital/Print Guide
Dena Battle — KCCure
Robert A. Figlin, MD, FACP — Cedars-Sinai Medical Center
Daniel J. George, MD — Duke University School of Medicine
Hans Hammers, MD, PhD — UT Southwestern
Tom Hutson, DO, PharmD — Charles A. Sammons Cancer Center, Baylor
Eric Jonasch, MD — The University of Texas MD Anderson Cancer Center
Richard W. Joseph, MD — Mayo Clinic
Bradley Leibovich, MD, FACS — Mayo Clinic
David F. McDermott, MD — Beth Israel Deaconess Medical Center
Robert J. Motzer, MD — Memorial Sloan-Kettering Cancer Center
Sumanta Kumar Pal, MD — City of Hope
Allan J. Pantuck, MD — UCLA School of Medicine
David I. Quinn, MBBS, PhD, FRACP — USC Oncology
Virginia Seery, MSN, RN, ANP-BC — Beth Israel Deaconess Medical Center
Martin Voss, MD — Memorial Sloan-Kettering Cancer Center
Christopher G. Wood, MD — The University of Texas MD Anderson Cancer Center
Laura S. Wood, MSN, RN, OCN — Cleveland Clinic Cancer Center
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org